The Oxford-AstraZeneca vaccine is a «viral vector» vaccine, when the vaccine is injected into a patient, it manifests as a carrier another virus adapted to fight Coronavirus. It prompts the immune system to start making antibodies for to attack any covid-19 infection.
British pharma giant AstraZeneca announced that its Oxford-AstraZeneca vaccine (AZD1222), is 70 percent effective in protecting against the virus. This vaccine can be kept at refrigerator temperatures of 2 to 8 degrees Celsius.
Inexpensive, practical and easy to store, it has many advantages :
The AstraZeneca / Oxford vaccine has the majore advantage of being inexpensive at a maximum cost of $5 a dose (about 4 euros ), and easy to store.
Suggested effective against the UK variant, AstraZeneca Group, said it will provide more two billion covidid-19 vaccine doses to 90 to low- and middle-income countries ($3 a dose) the majority are earmarked for delivery in the first half of the year (COVAX INITIATIVE) , pending WHO Emergency Use Listing.
Who will get the Oxford-AstraZeneca vaccine and when?
The UK has ordered 100 million doses of the Oxford-AstraZeneca vaccine, with the hope to about 100,000 doses will be received in the january 2021. AstraZeneca company signed deals to prepare at least 300 million doses for the U.S and more than 400 million for European Union members.
Risks and side effects of vaccination
Vaccines are only approved if overall benefits outweigh their risks. At the same time, the rapid development of COVID-19 vaccines has people asking questions, they also fear possible side effects from vaccination.
Vaccines are safe and save lives, It is normal to have certain reactions after a vaccination, although these side effects can be unpleasant. Most side effects last no more than a couple of days and you will recover without any problems.
Here is an overview of the reactions and side effects you can expect.
EU approves AstraZeneca vaccine
The European Medicines Agency (EMA) has approved the use of Oxford/AstraZeneca viral vector vaccine (developed by AstraZeneca and the University of Oxford) for all adults, The EU’s drugs regulator said: “The AstraZeneca vaccine was about 70% effective in the trials.” The covid-19 vaccine is already in use in the U.K, inde and canada.
India approves Oxford-AstraZeneca Covid-19 vaccine
The Indian government has approved the Oxford/AstraZeneca Covid-19 vaccine for emergency use India, which has the highest number of infections after the U.S, it is the first vaccine to get approval in India.
More than 50 million doses of the Oxford-AstraZeneca vaccine have already been stockpiled by the Serum Institute of India (SII), the vaccination programme aims to reach 200 million people by early July 2021.